Tarsus Pharmaceuticals Share Price (NASDAQ: TARS)

$58.55

▲

0.39

(0.67%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Tarsus Pharmaceuticals Stock chart to analyse performance

Tarsus Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$57.55
Today's High:$58.61
$58.55
1.72%
Downside
Day's Volatility :1.82%
Upside
0.1%
52 Weeks Low:$25.82
52 Weeks High:$58.95
$58.55
55.9%
Downside
52 Weeks Volatility :56.2%
Upside
0.67%

Tarsus Pharmaceuticals Stock Returns

Period	Tarsus Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	33.64%	3.6%	0.0%
6 Months	37.17%	-7.7%	0.0%
1 Year	123.92%	-12.6%	0.0%
3 Years	282.01%	9.5%	-4.7%

Tarsus Pharmaceuticals Inc Key Stats

Check Tarsus Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$58.16
Open	$57.545
Today's High	$58.61
Today's Low	$57.545
Market Capitalization	$2.5B
Today's Volume	$374.3K
52 Week High	$58.946
52 Week Low	$25.82
Revenue TTM	$295.5M
EBITDA	$-96.4M
Earnings Per Share (EPS)	$-2.29
Profit Margin	-31.13%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-31.46%

Stock Returns calculator for Tarsus Pharmaceuticals Stock including INR - Dollar returns

The Tarsus Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Tarsus Pharmaceuticals investment value today

Current value as on today

₹2,29,014

Returns

₹1,29,014

(+129.01%)

Returns from Tarsus Pharmaceuticals Stock

₹1,23,729 (+123.73%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Tarsus Pharmaceuticals Stock

200%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Tarsus Pharmaceuticals Stock from India on INDmoney has increased by 200% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Tarsus Pharmaceuticals Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
7.47%
RTW INVESTMENTS, LLC
7.37%
Paradigm Biocapital Advisors LP
7.05%
Jennison Associates LLC
5.85%
TANG CAPITAL MANAGEMENT LLC
5.82%
Vanguard Group Inc
5.44%

Analyst Recommendation on Tarsus Pharmaceuticals Stock

Rating

Trend

Buy

86%Buy

13%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Tarsus Pharmaceuticals(by analysts ranked 0 to 5 stars)

Tarsus Pharmaceuticals Share Price Target

What analysts predicted

Upside of 29.8%

Target:

$76.00

Current:

$58.55

Tarsus Pharmaceuticals share price target is $76.00, a slight Upside of 29.8% compared to current price of $58.55 as per analysts' prediction.

Tarsus Pharmaceuticals Stock Insights

Price Movement
In the last 1 month, TARS stock has moved up by 46.5%

Tarsus Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Tarsus Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Tarsus Pharmaceuticals Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Tarsus Pharmaceuticals Inc	43.59%	37.17%	123.92%	282.01%	184.74%
Regeneron Pharmaceuticals, Inc.	6.48%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	1.77%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-14.45%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	13.79%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Tarsus Pharmaceuticals Inc	NA	NA	NA	-1.5	-0.31	-0.14	NA	7.88
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Tarsus Pharmaceuticals Inc	Buy	$2.5B	184.74%	NA	-31.13%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is also developing TP-04 for the treatment of Ocular Rosacea; TP-05 for potential Lyme disease prophylaxis; and community malaria reduction. In addition, the company develops lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Organization	Tarsus Pharmaceuticals
Employees	323
CEO	Dr. Bobak R. Azamian M.D.
Industry	Health Technology

Key Management of Tarsus Pharmaceuticals Inc

Name	Title
Dr. Bobak R. Azamian M.D.	Co-Founder, President, CEO & Chairman
Mr. Jeffrey S. Farrow CPA	CFO & Chief Strategy Officer
Dr. Seshadri Neervannan Ph.D.	Chief Operating Officer
Mr. Aziz Mottiwala M.B.A.	Chief Commercial Officer
Dr. Elizabeth Yeu M.D.	Chief Medical Officer
Mr. David Nakasone	Head of Investor Relations
Dr. Bryan Wahl J.D., M.D.	General Counsel & Corporate Secretary
Ms. Adrienne Kemp	Senior Director of Corporate Communications
Mr. Matthew Rossen M.B.A.	Vice President of Marketing
Mr. Scott Youmans	Vice President of Sales

Important FAQs about investing in TARS Stock from India :

What is Tarsus Pharmaceuticals share price today?

Tarsus Pharmaceuticals share price today is $58.55 as on August 30, 2025 at 1:29 am IST at the close of the market. Tarsus Pharmaceuticals share today touched a day high of $58.61 and a low of $57.55.

What is the 52 week high and 52 week low for Tarsus Pharmaceuticals share?

Tarsus Pharmaceuticals share touched a 52 week high of $58.95 and a 52 week low of $25.82. Tarsus Pharmaceuticals stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $58.55, lower by 0.67% versus the 52 week high.

How to invest in Tarsus Pharmaceuticals Stock (TARS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tarsus Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tarsus Pharmaceuticals Shares that will get you 0.0256 shares as per Tarsus Pharmaceuticals share price of $58.55 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tarsus Pharmaceuticals Stock (TARS) from India?

Indian investors can start investing in Tarsus Pharmaceuticals (TARS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Tarsus Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Tarsus Pharmaceuticals share’s latest price of $58.55 as on August 30, 2025 at 1:29 am IST, you will get 0.1708 shares of Tarsus Pharmaceuticals. Learn more about fractional shares .

What are the returns that Tarsus Pharmaceuticals has given to Indian investors in the last 5 years?

Tarsus Pharmaceuticals stock has given 184.74% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?